Neurological symptoms are increasingly being observed in patients with COVID-19; this Comment article considers whether cross-reactive antibodies might contribute to the pathology associated with SARS-CoV-2 infection.
- Jakob Kreye
- S. Momsen Reincke
- Harald Prüss
